|
Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting |
Neubauer MA, Hoverman JR, Kolodziej M, Reisman L, Gruschkus SK, Hoang S, Alva AA, McArthur M, Forsyth M, Rothermel T, Beveridge RA |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Neubauer MA, Hoverman JR, Kolodziej M, Reisman L, Gruschkus SK, Hoang S, Alva AA, McArthur M, Forsyth M, Rothermel T, Beveridge RA. Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting. Journal of Oncology Practice 2010; 6(1): 12-18 Indexing Status Subject indexing assigned by CRD MeSH Carcinoma, Non-Small-Cell Lung; Community Health Services; Cost-Benefit Analysis; Humans; Lung Neoplasms; Practice Guidelines as Topic; United States AccessionNumber 22010000855 Date bibliographic record published 13/04/2011 |
|
|
|